Directory
>
Gregory Gin
Gregory Gin
Director, Capital Markets Intelligence | Abeona Therapeutics
New York City Metropolitan Area United States, United States
Gregory Gin
Summary
Gregory Gin is a seasoned professional in the field of investor relations and corporate communications, currently serving as Vice President at Abeona Therapeutics. With a strong background that includes leadership positions at several biotech firms, Gregory has a proven track record in capital markets and strategic communications. His experience spans across various roles, including Head of Investor Relations at Affimed and Edge Therapeutics, where he successfully navigated complex financial landscapes. Gregory's expertise is complemented by a deep understanding of the biotechnology industry, making him a valuable asset in corporate strategy and stakeholder engagement. He has demonstrated adaptability throughout his career, transitioning between roles in both corporate and consulting environments. Known for his analytical skills and strategic thinking, Gregory is committed to driving growth and fostering strong investor relationships. His leadership style is characterized by collaboration and transparency, essential traits in today's fast-paced business environment.
Gregory Gin
Work Experience
Vice President, Investor Relations and Corporate Communications at
Abeona Therapeutics
May 2020 - Present
Frequently Asked Questions about Gregory Gin
What is Gregory Gin email address?
Gregory Gin's primary email address is ****@evcgroup.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Gregory Gin work for?
Gregory Gin is a Director, Capital Markets Intelligence at Abeona Therapeutics.
How can I directly contact Gregory Gin?
To contact Gregory Gin directly, you can use the email address ****@evcgroup.com. Complete contact information is available upon registration with Muraena.
Who is Gregory Gin?
Gregory Gin is a seasoned professional in the field of investor relations and corporate communications, currently serving as Vice President at Abeona Therapeutics. With a strong background that includes leadership positions at several biotech firms, Gregory has a proven track record in capital markets and strategic communications. His experience spans across various roles, including Head of Investor Relations at Affimed and Edge Therapeutics, where he successfully navigated complex financial landscapes. Gregory's expertise is complemented by a deep understanding of the biotechnology industry, making him a valuable asset in corporate strategy and stakeholder engagement. He has demonstrated adaptability throughout his career, transitioning between roles in both corporate and consulting environments. Known for his analytical skills and strategic thinking, Gregory is committed to driving growth and fostering strong investor relationships. His leadership style is characterized by collaboration and transparency, essential traits in today's fast-paced business environment.
Gregory`s contact details
****@evcgroup.com
****@abeonatherapeutics.com
Colleagues
Sr Regulatory Associate
Summer Intern
QC Analyst
Global Senior Manager
Senior Audit Associate
Postdoctoral Researcher
Research Associate
Shift Team Leader/Crisis Worker